Interestingly, in breast cancer cells the ILEI-uPAR score, which is indicative of the potential for active secreted ILEI, was shown to be significantly correlated with the HER2 status of the tumor cells [13] suggesting that these three signaling pathways may cooperate to increase invasiveness. This evidence concerns the gene ERBB2 and breast cancer.